DATE : 2013-30-17
Solvay announces it has doubled the capacity of specialty fluoroaliphatic derivatives production in Salindres to support the strong growth in its strategic markets. In Jun 2012, Solvay had committed to increase its capacity production in a three-year investment plan to better serve its customers and support their growth plans. One year ahead of schedule, Solvay Aroma Performance successfully increased its production capacity for triflic acid and anhydride (TA, TAA), as well as the upstream intermediates such as potassium trifluoromethanesulfinate (TFSK).
Moreover, the downstream Lithium Bis (Trifluoromethanesulfonyl) Imide (LiTFSI) production capacity in China has also been doubled. This capacity increase allows Solvay Aroma Performance to meet the rapidly expanding requirements of downstream fluorinated products for applications such as liquid crystals, pharmaceutical intermediates and battery markets. "This investment decided in June 2012 allows us to enhance the capacity of our entire fluoroaliphatic derivatives production at Salindres in France. This fully integrated and unique value chain will support our customer expectations in terms of capacity but also quality and sustainability" highlights Remi Rothea, WW Performance Solutions Business Director.
Solvay announces it has doubled the capacity of specialty fluoroaliphatic derivatives production in Salindres to support the strong growth in its strategic markets. In Jun 2012, Solvay had committed to increase its capacity production in a three-year investment plan to better serve its customers and support their growth plans. One year ahead of schedule, Solvay Aroma Performance successfully increased its production capacity for triflic acid and anhydride (TA, TAA), as well as the upstream intermediates such as potassium trifluoromethanesulfinate (TFSK).
Moreover, the downstream Lithium Bis (Trifluoromethanesulfonyl) Imide (LiTFSI) production capacity in China has also been doubled. This capacity increase allows Solvay Aroma Performance to meet the rapidly expanding requirements of downstream fluorinated products for applications such as liquid crystals, pharmaceutical intermediates and battery markets. "This investment decided in June 2012 allows us to enhance the capacity of our entire fluoroaliphatic derivatives production at Salindres in France. This fully integrated and unique value chain will support our customer expectations in terms of capacity but also quality and sustainability" highlights Remi Rothea, WW Performance Solutions Business Director.
SOURCE Icis News